BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
FDS
FactSet Research Systems Inc.
FDS has a slight edge over BAC overall, supported by stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FDS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
FDS's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FDS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FDS in the historical PE scenario, which offers more potential upside but is not a forecast.
FDS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $332 | — |
| Current | 23x | $332 | — |
| Cheap | 24x | $349 | +5.3% |
| Fair | 33x | $487 | +47% |
| Expensive | 38x | $560 | +69% |
Historical ranges are pointers, not guarantees.
FDS's PE is in its cheap range at 23x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FDS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for FDS, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FDS on earnings, with more consistent year-over-year improvement.
FDS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.64 | +35% |
| Q3 2026 | $14.57 | -6.3% |
| Q2 2026 | $15.18 | +9.6% |
| Q1 2026 | $15.55 | +11% |
| Q4 2025 | $15.72 | +13% |
| Q3 2025 | $15.55 | +12% |
| Q2 2025 | $13.85 | +4.4% |
| Q1 2025 | $14.07 | +11% |
| Q4 2024 | $13.96 | +13% |
FDS earned $14.57 per share over the past year, down 6.3% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FDS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over FDS on profitability, with a higher operating margin.
FDS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $634.7M | +6.3% |
| Q2 2026 | $622.9M | +6.4% |
| Q1 2026 | $611M | +7.1% |
| Q4 2025 | $607.6M | +6.9% |
| Q3 2025 | $596.9M | +6.2% |
| Q2 2025 | $585.5M | +5.9% |
| Q1 2025 | $570.7M | +4.5% |
| Q4 2024 | $568.7M | +4.9% |
FDS's revenue has grown year over year every quarter since late 2020: $635M last quarter, up 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | -5 points |
| Q2 2026 | 27% | -6.5 points |
| Q1 2026 | 30% | -2.2 points |
| Q4 2025 | 32% | -2 points |
| Q3 2025 | 30% | +7 points |
| Q2 2025 | 33% | -3.5 points |
| Q1 2025 | 33% | -0.8 points |
| Q4 2024 | 34% | -1.2 points |
FDS's operating margin was 25% last quarter, down 5 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FDS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $177.3M | -0.5% |
| Q2 2026 | $254M | +11% |
| Q1 2026 | $185.7M | +24% |
| Q4 2025 | $90.4M | +49% |
| Q3 2025 | $178.1M | +30% |
| Q2 2025 | $228.6M | +5.4% |
| Q1 2025 | $150.2M | +23% |
| Q4 2024 | $60.5M | -56% |
FDS has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FDS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FDS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +421K shares |
| 1 year | -4.6% | -1.8M shares |
| 3 years | -5.9% | -2.3M shares |
| 5 years | -5.1% | -2M shares |
| Available history | -5.1% | -2M shares |
FDS has 37M diluted shares, down 4.6% from a year ago, with $644M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $138M |
| Q2 2026 | $203.1M |
| Q1 2026 | $163M |
| Q4 2025 | $139.9M |
| Q3 2025 | $106.6M |
| Q2 2025 | $80.7M |
| Q1 2025 | $64.4M |
| Q4 2024 | $48.8M |
FDS spent $644M buying back its own shares over the past year, up 114% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FDS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.3x | Healthy |
FDS has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FDS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.2 | Neutral |
| Stochastic | 83.5 | Overbought |
FDS's weekly RSI is 64 (neutral) and its Stochastic is 83 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over FDS on valuation relative to its sector.
FDS PE vs Financial Services Sector
| Metric | FDS | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 13x | 75% above |
| PE % | 17 | 63 | 46 pts below |
FDS is trading at 23x earnings, a 75% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FDS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $306.1 | 8.4% above |
| 20 week MA | $287.2 | 15% above |
| 50 week MA | $259.4 | 28% above |
| 100 week MA | $330.2 | 0.5% above |
| 200 week MA | $382.9 | 13% below |
FDS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FDS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $271.1 | $327.4 | +21% |
| 2021 | $327.4 | $479.5 | +46% |
| 2022 | $479.5 | $398.0 | -17% |
| 2023 | $398.0 | $477.1 | +20% |
| 2024 | $477.1 | $486.6 | +2% |
| 2025 | $486.6 | $292.1 | -40% |
| 2026 YTD | $292.1 | $331.7 | +14% |
FDS has the edge over BAC on returns for 2026, with the stronger performance.